secwatch.observer — SEC 8-K summary
======================================

Issuer:     CYTOKINETICS INC (CYTK)
CIK:        0001061983
Form:       8-K
Filed at:   2024-05-17T23:59:59+00:00
Accession:  0000950170-24-061275
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cytokinetics director Smith resigns; stockholders approve 300K-share ESPP increase
--------------------------------------------------------------------------------

- Sandford D. Smith resigned from the board effective before the 2024 annual meeting, not due to any disagreement.
- Stockholders approved amendment to ESPP increasing authorized shares by 300,000 to total 1,159,879 shares.
- Robert I. Blum and Robert A. Harrington elected as Class II directors for three-year terms.
- Ernst & Young LLP ratified as independent auditor for 2024; say-on-pay proposal passed advisory vote.
- Approximately 91.97% of eligible shares (96,181,650 votes) represented at the meeting, forming a quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1061983/000095017024061275/0000950170-24-061275-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1061983/000095017024061275/cytk-20240515.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-061275

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer